Table S1. Demographic and clinical characteristics of study participants stratified by female genital tract pro-inflammatory cytokine levels. Table S6. Details of MaxQuant version 1.5.7.4 parameters used for analysis of metaproteomic data obtained from lateral vaginal wall swabs from 113 women from Cape Town, South Africa. Figure S1. Clustering of women according to overall metaproteomic profiles. Figure S2. Identification of women with low, medium and high levels of pro-inflammatory cytokines and chemokines. Figure S3. Human biological processes, microbial taxa and microbial biological processes in individual women with low, medium and high inflammation. Figure S4. Differentially abundant proteins in women with high versus low inflammatory cytokine profiles. Figure S5. Top 50 significantly differentially abundant human biological processes in women with low, and high inflammation. Figure S6. Relative abundance of gene ontologies in BV negative women with Lactobacillus dominant communities. Figure S7. Longitudinal changes in FGT microbial biological process and cellular component gene ontologies. (PDF 6091 kb)